<DOC>
	<DOCNO>NCT00527943</DOCNO>
	<brief_summary>The study design determine whether vorapaxar , add exist standard care ( eg , aspirin , clopidogrel ) prevent heart attack stroke patient acute coronary syndrome , yield additional benefit exist standard care prevent heart attack stroke . The study also design assess risk bleed vorapaxar add standard care versus standard care alone .</brief_summary>
	<brief_title>Trial Assess Effects Vorapaxar ( SCH 530348 ; MK-5348 ) Preventing Heart Attack Stroke Particpants With Acute Coronary Syndrome ( TRAâ€¢CER ) ( Study P04736 )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Vorapaxar</mesh_term>
	<criteria>Men woman least 18 year old current clinical manifestation nonSTsegmentelevation myocardial infarction ( heart attack ) accord follow three criterion : current symptom cardiac ischemia ( chest pain lead cardiac ischemia heart attack ) AND either follow : concurrent elevation troponin I T , creatine kinase myocardial band ( CKMB ) level upper limit normal , OR concurrent appropriate electrocardiographic evidence AND one ( ) following : age &gt; = 55 year document history prior heart attack coronary revascularization ( eg , angioplasty [ PCI ] , coronary artery replacement [ CABG ] ) diabetes ( document use insulin oral hypoglycemic [ ] ) document history peripheral arterial disease history intracranial hemorrhage central nervous system ( CNS ) surgery , tumor , aneurysm bleed disorder abnormality sustain severe hypertension valvular heart disease current recent platelet count &lt; 100,000 mm^3 plan ongoing treatment blood thin medication pregnancy significant medical physiological condition abnormality could put subject increase risk limit subject 's ability participate duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>